alexa Disease Modifying Multiple Sclerosis Drugs|omicsgroup|Journal Of Multiple Sclerosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Disease Modifying Multiple Sclerosis Drugs

MS remains a mysterious disease with no known pathogen or even known determinants of its severity and Cause. The ultimate goal of research in MS is the development of interventions that can improve the lives of those living with MS and prevent or cure MS. However, understanding of the MS disease process is not yet sufficient to predict which therapeutic strategies will be most effective. While the new disease-modifying drugs are a major leap forward, they are not a cure, nor are they effective for all patients. MS remains a mysterious disease with no known pathogen or even known determinants of its severity and course Vasiliki E. Kalodimou et al Multiple Sclerosis & Research. Disease modifying multiple sclerosis drugs are not the ultimate cure for this autoimmune demyelinating disease but these drugs has the ability to reduce the relapses associated with the disease. Major among these disease modifying drugs include teriflunomide, interferon beta-1a, interferon beta-1b, glatiramer acetate. Apart from these there are many unlicensed disease modifying multiple sclerosis drugs commonly used and prescribed.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014

Top